Skip to main content

Table 2 Changes in lysophospholipids concentration (μM) categorized by changes in waist circumference and Weight loss

From: Changes in lysophospholipids and liver status after weight loss: the RESMENA study

 

All subjects (n = 33)

 

Δ Waist circumference (cm)

Δ Weight (kg)

Δ LP

Baseline

6 months

p-value

< P50

≥ P50

< P50

≥ P50

LPC 14:0

1.7 (0.1)

1.2 (0.1)

0.008

0.5 (1)

1.1 (1)

0.8 (1)

0.8 (1)

LPC 15:0

0.8 (0.05)

0.7 (0.04)

0.024

0.3 (0.5)

0.7 (0.4)*

0.4 (0.6)

0.6 (0.4)

LPC 16:0

147 (6)

136 (8)

0.231

83.2 (101)

158.0 (75)**

108.1 (67)

137.9 (112)

LPC 16:1

3.7 (0.2)

3 (0.19)

0.009

1.1 (2.4)

8.3 (1)*

2.1 (2)

2.4 (2)

LPC 17:0

3 (0.2)

2.6 (0.2)

0.105

1.1 (2)

3.1 (1)*

1.8 (2)

2.5 (2)

LPC 17:1

0.6 (0)

0.5 (0)

0.095

0.3 (0.4)

0.5 (0.2)

0.4 (0.4)

0.4 (0.3)

LPC 18:0

78.6 (4.8)

65.5 (5)

0.060

29.0 (66)

74.3 (51)*

37.2 (57)

66.6 (65)

LPC 18:1

55.8 (4.1)

49.8 (3.3)

0.189

24.9 (32)

61.6 (43)*

49.5 (34)

51.0 (48)

LPC 18:2

56.8 (3.2)

57 (4)

0.856

47.7 (48)

68.1 (43)

49.5 (34)

66.6 (54

LPC 18:3

81.4 (3.7)

77.4 (5.3)

0.503

50.0 (63)

92.6 (50)*

66.2 (38)

79.3 (72)

LPC 18:4

1.1 (0.06)

0.89 (0.05)

0.006

0.3 (0.6)

0.9 (0.4)*

0.6 (0.6)

0.7 (0.6)

LPC 20:0

0.31 (0.02)

0.29 (0.02)

0.547

0.2 (0.3)

0.2 (0.2)

0.3 (0.2)

0.2 (0.2)

LPC 20:1

0.84 (0.06)

0.74 (0.04)

0.124

0.4 (0.5)

0.8 (0.4)*

0.5 (0.4)

0.7 (0.5)

LPC 20:2

0.83 (0.06)

0.7 (0.04)

0.090

0.3 (0.6)

0.8 (0.3)*

0.4 (0.6)

0.6 (0.5)

LPC 20:3

9.94 (0.6)

8.77 (0.56)

0.214

6.0 (9)

9.0 (6)

7.2 (7)

7.8 (8)

LPC 20:4

36.5 (2)

31 (1.7)

0.026

16.2 (16)

34.5 (18)*

21.2 (17)

30.2 (21)

LPC 22:4

0.43 (0.02)

0.39 (0.02)

0.222

0.2 (0.3)

0.4 (0.2)

0.3 (0.3)

0.3 0.2)

LPC 22:5

1 (0.07)

0.98 (0.05)

0.256

0.7 (0.8)

0.9 (0.7)

0.8 (0.7)

0.8 (0.7)

LPC 22:6

7.8 (0.5)

6.6 (0.5)

0.093

0.7 (0.8)

0.9 (0.7)

0.9 (0.8)

0.8 (0.9)

LPE 18:0

25.7 (1.7)

23 (1.5)

0.230

15.1 (20)

24.9 (17)

20.6 (19)

20.0 (20)

LPE 18:1

3.8 (0.36)

3.57 (0.3)

0.627

3.1 (4)

3.5 (4)

3.5 (4)

3.1 (5)

LPE 18:2

4.1 (0.3)

3.9 (0.4)

0.803

4.2 (6)

3.4 (4)

4.0 (5)

3.6 (5.0)

LPE 20:0

6.7 (0.58)

5.7 (0.49)

0.202

3.3 (6)

6.1 (5)

4.9 (5)

4.8 (6)

LPE 20:2

5.2 (0.39)

5.1 (0.4)

0.911

4.4 (5.5)

5.7 (5)

4.7 (5)

5.4 (5)

LPE 20:3

0.43 (0.01)

0.42 (0.01)

0.872

0.4 (0.2)

3.0 (2)

0.4 (0.2)

0.4 (0.2)

LPE 20:4

3.37 (0.16)

3.15 (0.21)

0.427

2.8 (3.1)

0.2 (0.8)

3.1 (2)

2.7 (2)

LPE 20:5

0.75 (0.06)

0.77 (0.16)

0.917

1.3 (2.4)

0.5 (0.2)

1.1 (2)

0.4 (0.9)

LPE 22:4

0.46 (0.01)

0.48 (0.02)

0.332

0.4 (0.2)

0.5 (0.2)

0.4 (0.2)

0.5 (0.3)

LPE 22:5

0.27 (0.0)

0.27 (0.0)

0.931

0.2 (0.1)

0.2 (0.09)

0.2 (0.09)

0.2 (0.1)

LPE 22:6

1.9 (0.13)

1.66 (0.1)

0.054

1.05 (1)

1.6 (0.9)

1.5 (1)

1.1 (1)

LPI 18:0

2.5 (0.2)

2.2 (0.23)

0.367

1.2 (3)

2.5 (2)

1.7 (3)

2.1 (2)

LPI 18:1

0.61 (0.06)

0.5 (0.03)

0.105

0.3 (0.5)

0.4 (0.4)

0.4 (0.4)

0.3 (0.5)

Scores of lysophospholipids

 ∑LPC-s

2.5 (14)

−5.4 (13)*

0.027

0.1 (0.5)

−0.8 (1)*

−0.5 (0.1)

−0.1 (0.8)

 ∑LPE-s

0.5 (7)

−0.8 (8)

0.495

−0.2 (1)

−0.2 (1)

−0.1 (1)

−0.03 (1)

 ∑LPI-s

0.2 (1)

−0.3 (1)

0.178

−0.65 (1)

−0.03 (1)

− 0.4 (1)

−0.2 (1)

 ∑LPstotal

2.6 (19)

−9.2 (20)*

0.024

−0.07 (0.5)

−0.6 (0.8)*

− 0.2 (0.6)

−0.5 (0.8)

  1. Paired test was carried out. Mean (SD). * P-values considered < 0.05 and **P-values were p < 0.001. P-values were adjusted by Ancova test was performed adjusting by LP value at baseline, sex and gender. ∑LPCs is lysophosphatidylcholine score, ∑LPEs is lysophosphatidylethanolamine score; ∑LPIs is lysophosphatidylinositols score; ∑LPstotal is lysophospholipis total score